Arbutus Biopharma Corp (ABUS)

SG&A Expenses

$3.87M

Quarterly · Period ending: · USD

ABUS logo

ABUS SG&A Expenses

Latest reported$3.87M
ABUS Quarterly SG&A Expenses ($1.56M → $3.87M)
High-resolution chart · PNG

ABUS sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
3,867,000
5,878,000
3,700,000
3,033,000
3,328,000
5,832,000
8,432,000
4,537,000
7,547,000
5,312,000
5,101,000
5,842,000
5,980,000
5,552,000
4,249,000
3,493,000
5,200,000
4,892,000
4,597,000
4,183,000
4,478,000
3,878,000
3,661,000
4,065,000
3,566,000
3,553,000
1,877,000
3,249,000
8,189,000
4,412,000
5,927,000
2,631,000
3,775,000
3,669,000
3,543,000
3,659,000
4,599,000
4,328,000
4,733,000
3,720,000
23,766,000
7,219,000
8,354,000
7,706,000
7,700,000
2,716,000
3,082,000
1,764,000
1,787,000
2,050,000
2,849,219
958,782
830,621
903,452
21,070,862
1,528,714
2,363,447
1,825,732
1,996,654
1,163,903
1,646,250
1,586,154
1,331,354
1,436,357
1,025,506
976,331
1,138,678
870,377
964,348
769,742
230,997
1,042,870
1,769,193
662,212
1,050,647
810,750
1,561,876
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.